Hybrid: US FDA / UK MHRA / HC Symposium – Regulatory Perspectives in Good Clinical Practice, Bioequivalence and Good Pharmacovigilance Practice
Date
Time
Location
Organizer
Hybrid: US FDA / UK MHRA / HC Symposium – Regulatory Perspectives in Good Clinical Practice, Bioequivalence and Good Pharmacovigilance Practice
Health Canada, UK MHRA (Medicines and Healthcare products Regulatory Agency), US FDA (U.S. Food and Drug Administration)
Event Categories
Venue
Registration Link
Hybrid: US FDA / UK MHRA / HC Symposium – Regulatory Perspectives in Good Clinical Practice, Bioequivalence and Good Pharmacovigilance Practice
This hybrid symposium will bring together regulators from the US FDA, UK MHRA, and Health Canada to share perspectives on Good Clinical Practice (ICH E6), Bioequivalence, and Good Pharmacovigilance Practice. Attendees can join in person or virtually.
Stay tuned — more details on sessions and speakers will be shared in the coming months.
More Upcoming Events
